相似文献
1
Antagonist: population based endoscopic screening for colorectal cancer.
Gut. 2003 Mar;52(3):323-6. doi: 10.1136/gut.52.3.323.
2
Screening for colorectal cancer--which strategy is the best?
J Natl Cancer Inst. 2011 Sep 7;103(17):1282-3. doi: 10.1093/jnci/djr300. Epub 2011 Aug 18.
3
Screening sigmoidoscopy for colorectal cancer.
Lancet. 2003 Oct 11;362(9391):1167-8. doi: 10.1016/S0140-6736(03)14553-9.
4
Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
J Natl Cancer Inst. 2005 Mar 2;97(5):347-57. doi: 10.1093/jnci/dji050.
5
Population-based fecal occult blood screening for colon cancer: will the benefits outweigh the harm?
CMAJ. 2000 Sep 5;163(5):545-6; discussion 547.
6
Making a difference through colorectal cancer screening.
Ala Nurse. 2013 Jun-Aug;40(2):20.
7
Colorectal cancer screening.
J Intern Med. 2011 Aug;270(2):87-98. doi: 10.1111/j.1365-2796.2011.02399.x. Epub 2011 Jun 9.
8
The best screening test for colorectal cancer--a personal choice.
N Engl J Med. 2000 Nov 30;343(22):1641-3. doi: 10.1056/NEJM200011303432211.
9
Trends in colorectal cancer testing among Medicare subpopulations.
Am J Prev Med. 2008 Sep;35(3):194-202. doi: 10.1016/j.amepre.2008.05.029. Epub 2008 Jul 10.
10
Protagonist: population based endoscopic screening for colorectal cancer.
Gut. 2003 Mar;52(3):321-2. doi: 10.1136/gut.52.3.321.
引用本文的文献
1
Primary and secondary prevention of colorectal cancer.
Clin Med Insights Gastroenterol. 2014 Jul 14;7:33-46. doi: 10.4137/CGast.S14039. eCollection 2014.
2
FIT testing: an overview.
Curr Gastroenterol Rep. 2013 Nov;15(11):357. doi: 10.1007/s11894-013-0357-x.
3
Incidence of colorectal cancer in Poland in 1999-2008.
Arch Med Sci. 2011 Aug;7(4):673-8. doi: 10.5114/aoms.2011.24138. Epub 2011 Sep 2.
4
Screening techniques for prevention and early detection of colorectal cancer in the average-risk population.
Gastrointest Cancer Res. 2007 May;1(3):98-106.
5
Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.
Gut. 2007 Feb;56 Suppl 1(Suppl 1):1-113. doi: 10.1136/gut.2006.117598.
6
Screening tests for colorectal cancer: a menu of options remains relevant.
Curr Oncol Rep. 2006 Nov;8(6):492-8. doi: 10.1007/s11912-006-0079-4.
本文引用的文献
1
The colorectal adenoma-carcinoma sequence.
Br J Surg. 2002 Jul;89(7):845-60. doi: 10.1046/j.1365-2168.2002.02120.x.
2
Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial.
Lancet. 2002 Apr 13;359(9314):1291-300. doi: 10.1016/S0140-6736(02)08268-5.
3
Detection of APC mutations in fecal DNA from patients with colorectal tumors.
N Engl J Med. 2002 Jan 31;346(5):311-20. doi: 10.1056/NEJMoa012294.
4
Clinical practice. Screening for colorectal cancer.
N Engl J Med. 2002 Jan 3;346(1):40-4. doi: 10.1056/NEJMcp010886.
5
Stool screening for colorectal cancer: evolution from occult blood to molecular markers.
Clin Chim Acta. 2002 Jan;315(1-2):157-68. doi: 10.1016/s0009-8981(01)00712-4.
6
Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial.
Gut. 2001 Jul;49(1):91-6. doi: 10.1136/gut.49.1.91.
7
Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening.
Gut. 2001 Apr;48(4):522-5. doi: 10.1136/gut.48.4.522.
8
The effect of fecal occult-blood screening on the incidence of colorectal cancer.
N Engl J Med. 2000 Nov 30;343(22):1603-7. doi: 10.1056/NEJM200011303432203.
9
Cost-effectiveness of screening for colorectal cancer in the general population.
JAMA. 2000 Oct 18;284(15):1954-61. doi: 10.1001/jama.284.15.1954.
10
Cost-effectiveness of colonoscopy in screening for colorectal cancer.
Ann Intern Med. 2000 Oct 17;133(8):573-84. doi: 10.7326/0003-4819-133-8-200010170-00007.
Zotero 插件